Virulence factors profiles and ESBL production in Escherichia coli causing bacteremia in Peruvian children

Diagn Microbiol Infect Dis. 2016 Sep;86(1):70-5. doi: 10.1016/j.diagmicrobio.2016.05.017. Epub 2016 May 27.

Abstract

The presence of 25 virulence genes (VGs), genetic phylogroups, quinolone-resistance and Extended Spectrum β-lactamase (ESBL)-production was assessed in 65 Escherichia coli isolates from blood cultures in children <5 years in Peru. The most frequent VGs were fimA (89.2%), iutA (83.1%), agn43 (72.3%), iucA (67.7%), and fyuA (49.2%). The isolates belonged to D (47.7%), A (26.1%), B1 (21.5%), and B2 (4.6%) phylogroups. D + B2 isolates presented a high number of fimA, hly, papC, sat, and fyuA genes. Quinolone-susceptible (22 isolates - 33.8%) and ESBL-negative (31 isolates - 47.7%) isolates carried more VGs that their respective counterparts (5.7 vs. 4.7 and 5.3 vs. 4.4 respectively); the frequency of the fyuA, aat, aap, and hly genes significantly differed between quinolone-resistant and quinolone-susceptible isolates. Neonatal sepsis isolates tended to be more quinolone-resistant (P = 0.0697) and ESBL-producers (P = 0.0776). Early-onset neonatal sepsis isolates possessed a high number of VGs (5.2 VGs), especially in neonates of ≤1 day (5.9 VGs).

Keywords: Bacteremia; ESBL; Extra-intestinal Escherichia coli; Neonatal sepsis; Quinolone-resistance; Virulence.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / microbiology*
  • Blood / microbiology
  • Child, Preschool
  • Drug Resistance, Bacterial
  • Escherichia coli / classification
  • Escherichia coli / enzymology*
  • Escherichia coli / isolation & purification
  • Escherichia coli / pathogenicity*
  • Escherichia coli Infections / microbiology*
  • Female
  • Genotype
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Peru
  • Quinolones / pharmacology
  • Virulence Factors / analysis*
  • Virulence Factors / genetics
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Quinolones
  • Virulence Factors
  • beta-Lactamases